In The Fed’s Inflation Fight, Biotech May Be The First Casualty
Posted: Sep 20th, 2022In: Opinions & FeaturesSerious thought should be given to the effect the anticipated Federal Reserve 0.75% rate hike will have on the biotechnology industry and consequently on the health of the nation.
Read More about In The Fed’s Inflation Fight, Biotech May Be The First CasualtyCan The “New” CDC Meet The Monkeypox Challenge?
Posted: Aug 18th, 2022In: Opinions & FeaturesCan the New CDC meet the monkeypox challenge? What will happen when your child’s school reports the first case of monkeypox? It isn't a question of if, it's a question of when. Monkeypox may not[...]
Read More about Can The “New” CDC Meet The Monkeypox Challenge?
5 Musts To Achieve Covid-19 Independence
Posted: Jul 2nd, 2022In: Opinions & Features, SARS-CoV-2Far from cause for celebration, this 4th of July marks the 6th wave of Covid-19, with BA.4 and BA.5 variants leading the parade.
Read More about 5 Musts To Achieve Covid-19 Independence
Lessons from earlier pandemics: Vaccine panel must discuss imprinting among infants and toddlers
Posted: Jun 13th, 2022In: Opinions & Features, SARS-CoV-2This week, when the CDC’s vaccine advisory committee considers approving the Moderna and Pfizer/BioNTech mRNA Covid-19 vaccines for infants and toddlers, the issue of imprinting may not be on the agenda.
Read More about Lessons from earlier pandemics: Vaccine panel must discuss imprinting among infants and toddlersA Virtual Covid-19 Summit With Virtually No Chance Of Success
Posted: May 12th, 2022In: Opinions & Features, SARS-CoV-2Today, using a virtual structure, the World’s leadership including President Biden, will launch the Second Covid-19 Summit to “redouble the efforts” to control the pandemic.
Read More about A Virtual Covid-19 Summit With Virtually No Chance Of SuccessFDA’s Vaccine Panel Questions The Sustainability Of Our Covid-19 Strategy
Posted: Apr 8th, 2022In: Opinions & Features, SARS-CoV-2These last ten days have been the most important in coming to an understanding of our Covid-19 vaccination strategy.
Read More about FDA’s Vaccine Panel Questions The Sustainability Of Our Covid-19 StrategyFrom Hubris To Humility, How To Avoid Future Covid-19 Mistakes And Get To The “Next Normal”
Posted: Mar 12th, 2022In: Opinions & Features, SARS-CoV-2In the face of grave challenges like Covid-19, humility works better than hubris. As information savvy and technologically advanced as we humans are, we can’t know everything. And the rejoinder to this dilemma is we[...]
Read More about From Hubris To Humility, How To Avoid Future Covid-19 Mistakes And Get To The “Next Normal”Public Health Experts Outline Roadmap For The ‘Next Normal’ Of The Covid-19 Pandemic
Posted: Mar 7th, 2022In: Opinions & Features, SARS-CoV-2Getting to and Sustaining the Next Normal: A Roadmap for Living with COVID is a blueprint written by a who’s who of health, scientific, and policy experts as a comprehensive report to set us on[...]
Read More about Public Health Experts Outline Roadmap For The ‘Next Normal’ Of The Covid-19 Pandemic
McDonald’s Test Meal: A 3-Part Sandwich To Test Our Health?
Posted: Feb 4th, 2022In: Opinions & FeaturesIt’s called Land, Air & Sea. And, no, I am not referring to a parody of the US Marines’ Hymn, in whose service I am a proud retiree.
Read More about McDonald’s Test Meal: A 3-Part Sandwich To Test Our Health?JAMA Publishes The Most Important Covid-19 Plan To Date – The New Normal
Posted: Jan 6th, 2022In: Opinions & Features, SARS-CoV-2Today, a group of eminent physicians and scientists with global standing have acted decisively and in unison presenting the world with what it badly needs, whether it knows it or not: a comprehensive, cohesive plan[...]
Read More about JAMA Publishes The Most Important Covid-19 Plan To Date – The New Normal